Edition:
United States

Alliance Pharma PLC (ALAPH.L)

ALAPH.L on London Stock Exchange

47.75GBp
23 Mar 2017
Change (% chg)

0.25 (+0.53%)
Prev Close
47.50
Open
48.50
Day's High
50.00
Day's Low
47.56
Volume
128,453
Avg. Vol
611,394
52-wk High
54.50
52-wk Low
40.50

Latest Key Developments (Source: Significant Developments)

Alliance Pharma updates on settlement agreement with Sinclair Pharma
Tuesday, 21 Mar 2017 03:00am EDT 

Alliance Pharma Plc : Settlement agreement with sinclair pharma plc . Reached agreement with Sinclair Pharma for compensation in connection with material reduction of business in Kelo-Stretch™ . Terms are: £4 million in cash to be paid to Coby Sinclair on or before 30 April; £1 million to be paid to co by sinclair on or before 30 June 2018 . Sinclair relinquishes any and all rights to Flammacerium™ (US) with immediate effect and transfers them to company .Cash element of compensation will be used by company to reduce its current bank loans..  Full Article

Alliance Pharma says does not see any issues over market access
Tuesday, 19 Jul 2016 02:00am EDT 

Alliance Pharma Plc : Do not anticipate any issues over market access due to uk's decision to leave european union . If current exchange rates prevail sees modest benefit to our sales and financial performance . H1 sales 3.5 million stg . Performed in line with board's expectations with sales more than doubling to £46.4m (2015: £22.8m) for 6 mths to 30 june . Too early to assess long-term impact of uk's decision to leave european union .Do not expect to be adversely affected by current sterling exchange rate volatility.  Full Article

Alliance Pharma plc declares dividend
Monday, 14 Sep 2015 06:31am EDT 

Alliance Pharma plc:Declares an interim payment of 0.366p per ordinary share (H1 2014: 0.333p).Says the interim dividend will be paid on Jan. 14, 2016 to shareholders on the register on Dec. 21.  Full Article

Alliance Pharma plc appoints finance director
Friday, 10 Jul 2015 02:00am EDT 

Alliance Pharma plc:Says the appointment of Andrew Franklin as Finance Director.Andrew will join the company and the Board with effect from Sept. 28.  Full Article

More From Around the Web

BRIEF-Alliance Pharma updates on settlement agreement with Sinclair Pharma

* Reached agreement with Sinclair Pharma for compensation in connection with material reduction of business in Kelo-Stretch™

No consensus analysis data available.